Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1989 1
1990 1
1991 4
1993 2
1994 2
1995 1
1996 2
1997 1
1998 1
1999 2
2001 3
2002 1
2003 3
2004 5
2005 6
2006 5
2007 8
2008 12
2009 8
2010 9
2011 8
2012 8
2013 7
2014 6
2016 4
2017 6
2018 10
2019 14
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Results by year
Filters applied: . Clear all
Page 1
Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis.
Xing F, Liu Y, Wu SY, Wu K, Sharma S, Mo YY, Feng J, Sanders S, Jin G, Singh R, Vidi PA, Tyagi A, Chan MD, Ruiz J, Debinski W, Pasche BC, Lo HW, Metheny-Barlow LJ, D'Agostino RB Jr, Watabe K. Xing F, et al. Among authors: pasche bc. Cancer Res. 2018 Aug 1;78(15):4316-4330. doi: 10.1158/0008-5472.CAN-18-1102. Epub 2018 Jul 19. Cancer Res. 2018. PMID: 30026327 Free PMC article.
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq.
Song Q, Hawkins GA, Wudel L, Chou PC, Forbes E, Pullikuth AK, Liu L, Jin G, Craddock L, Topaloglu U, Kucera G, O'Neill S, Levine EA, Sun P, Watabe K, Lu Y, Alexander-Miller MA, Pasche B, Miller LD, Zhang W. Song Q, et al. Among authors: pasche b. Cancer Med. 2019 Jun;8(6):3072-3085. doi: 10.1002/cam4.2113. Epub 2019 Apr 29. Cancer Med. 2019. PMID: 31033233 Free PMC article.
Atad3a suppresses Pink1-dependent mitophagy to maintain homeostasis of hematopoietic progenitor cells.
Jin G, Xu C, Zhang X, Long J, Rezaeian AH, Liu C, Furth ME, Kridel S, Pasche B, Bian XW, Lin HK. Jin G, et al. Among authors: pasche b. Nat Immunol. 2018 Jan;19(1):29-40. doi: 10.1038/s41590-017-0002-1. Epub 2017 Nov 21. Nat Immunol. 2018. PMID: 29242539 Free PMC article.
TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
Sirkisoon SR, Carpenter RL, Rimkus T, Doheny D, Zhu D, Aguayo NR, Xing F, Chan M, Ruiz J, Metheny-Barlow LJ, Strowd R, Lin J, Regua AT, Arrigo A, Anguelov M, Pasche B, Debinski W, Watabe K, Lo HW. Sirkisoon SR, et al. Among authors: pasche b. Oncogene. 2020 Jan;39(1):64-78. doi: 10.1038/s41388-019-0959-3. Epub 2019 Aug 28. Oncogene. 2020. PMID: 31462709 Free PMC article.
Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study.
Li X, Zhang S, Zhang Q, Wei X, Pan Y, Zhao J, Xin X, Qin C, Wang X, Li J, Yang F, Zhao Y, Yang M, Wang Q, Zheng Z, Zheng X, Yang X, Whitlow CT, Gurcan MN, Zhang L, Wang X, Pasche BC, Gao M, Zhang W, Chen K. Li X, et al. Among authors: pasche bc. Lancet Oncol. 2019 Feb;20(2):193-201. doi: 10.1016/S1470-2045(18)30762-9. Epub 2018 Dec 21. Lancet Oncol. 2019. PMID: 30583848 Free PMC article. Clinical Trial.
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
Alistar A, Morris BB, Desnoyer R, Klepin HD, Hosseinzadeh K, Clark C, Cameron A, Leyendecker J, D'Agostino R Jr, Topaloglu U, Boteju LW, Boteju AR, Shorr R, Zachar Z, Bingham PM, Ahmed T, Crane S, Shah R, Migliano JJ, Pardee TS, Miller L, Hawkins G, Jin G, Zhang W, Pasche B. Alistar A, et al. Among authors: pasche b. Lancet Oncol. 2017 Jun;18(6):770-778. doi: 10.1016/S1470-2045(17)30314-5. Epub 2017 May 8. Lancet Oncol. 2017. PMID: 28495639 Free PMC article. Clinical Trial.
Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF.
Sharma S, Wu SY, Jimenez H, Xing F, Zhu D, Liu Y, Wu K, Tyagi A, Zhao D, Lo HW, Metheny-Barlow L, Sun P, Bourland JD, Chan MD, Thomas A, Barbault A, D'Agostino RB, Whitlow CT, Kirchner V, Blackman C, Pasche B, Watabe K. Sharma S, et al. Among authors: pasche b. EBioMedicine. 2019 Jun;44:194-208. doi: 10.1016/j.ebiom.2019.05.038. Epub 2019 May 23. EBioMedicine. 2019. PMID: 31129098 Free PMC article.
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Liu L, Ruiz J, O'Neill SS, Grant SC, Petty WJ, Yang M, Chen K, Topaloglu U, Pasche B, Zhang W. Liu L, et al. Among authors: pasche b. Mol Cancer. 2018 Apr 12;17(1):81. doi: 10.1186/s12943-018-0832-y. Mol Cancer. 2018. PMID: 29650000 Free PMC article.
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery.
McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR, Shen C, Kleinberg L, Contessa JN, Corso C, Chiang V, Henson-Masters A, Cramer CK, Ruiz J, Pasche B, Watabe K, D'Agostino R, Su J, Laxton AW, Tatter SB, Fiveash JB, Ahluwalia M, Kotecha R, Chao ST, Braunstein SE, Attia A, Chung C, Chan MD. McTyre ER, et al. Among authors: pasche b. Radiother Oncol. 2020 Jan;142:168-174. doi: 10.1016/j.radonc.2019.08.011. Epub 2019 Sep 13. Radiother Oncol. 2020. PMID: 31526671 Clinical Trial.
133 results
Jump to page
Feedback